Publications by authors named "Rashed A Ghandour"

Claim this Profile
P
Predictive model for systemic recurrence following cisplatin-based neoadjuvant chemotherapy and radical nephroureterectomy for high risk upper tract urothelial carcinoma.
Rashed A Ghandour, Yuval Freifeld, Joseph Cheaib, Nirmish Singla, Xiaosong Meng

Urol Oncol· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pathologic stage as a surrogate for oncologic outcomes after receipt of neoadjuvant chemotherapy for high-grade upper tract urothelial carcinoma.
Nirmish Singla, Alana Christie, Yuval Freifeld, Rashed A Ghandour, Solomon L Woldu

Urol Oncol· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Overcoming sociodemographic factors in the care of patients with testicular cancer at a safety net hospital.
Nathan Chertack, Rashed A Ghandour, Nirmish Singla, Yuval Freifeld, Ryan C Hutchinson

Cancer· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Does grossly complete transurethral resection improve response to neoadjuvant chemotherapy?
Rashed A Ghandour, Samuel Kusin, Daniel Wong, Xiaosong Meng, Nirmish Singla

Urol Oncol· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Improved survival after cytoreductive nephrectomy for metastatic renal cell carcinoma in the contemporary immunotherapy era: An analysis of the National Cancer Database.
Nirmish Singla, Ryan C Hutchinson, Rashed A Ghandour, Yuval Freifeld, Dong Fang

Urol Oncol· June 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rational Approaches to Treatment Duration with Immunotherapy in Metastatic Renal Cell Carcinoma.
Nirmish Singla, Yuval Freifeld, Rashed A Ghandour, Hans J Hammers

Eur Urol Focus· January 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pathologic response and surgical outcomes in patients undergoing nephrectomy following receipt of immune checkpoint inhibitors for renal cell carcinoma.
Nirmish Singla, Roy Elias, Rashed A Ghandour, Yuval Freifeld, Isaac A Bowman

Urol Oncol· December 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Site of extranodal metastasis impacts survival in patients with testicular germ cell tumors.
Hiten D Patel, Nirmish Singla, Rashed A Ghandour, Yuval Freifeld, Joseph G Cheaib

Cancer· November 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Is cytoreductive nephrectomy relevant in the immunotherapy era?
Nirmish Singla, Rashed A Ghandour, Vitaly Margulis

Curr Opin Urol· September 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Management of Stage II Germ Cell Tumors.
Rashed A Ghandour, Nirmish Singla, Aditya Bagrodia

Urol Clin North Am· August 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Genetics of testicular germ cell tumors.
Nirmish Singla, John T Lafin, Rashed A Ghandour, Samuel Kaffenberger, James F Amatruda

Curr Opin Urol· July 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Biomarkers for platinum sensitivity in bladder cancer: are we there yet?
Nirmish Singla, Rashed A Ghandour, Ganesh V Raj

Transl Androl Urol· July 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sex differences in upper tract urothelial carcinomas.
Nirmish Singla, Rashed A Ghandour, Vitaly Margulis

Curr Opin Urol· May 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The use of cytoreductive nephrectomy in patients with renal cell carcinoma.
Rashed A Ghandour, Nirmish Singla, Vitaly Margulis

Expert Rev Anticancer Ther· May 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Investigational luteinizing hormone releasing hormone (LHRH) agonists and other hormonal agents in early stage clinical trials for prostate cancer.
Nirmish Singla, Rashed A Ghandour, Ganesh V Raj

Expert Opin Investig Drugs· March 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Partial Cystectomy for Primary Bladder Tumors in Contemporary Patients with Diverse Tumor Locations.
Matthew R Danzig, Ari R Berg, Rashed A Ghandour, Danny Lascano, Michael J Whalen

Urol Pract· January 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Active Surveillance is Superior to Radical Nephrectomy and Equivalent to Partial Nephrectomy for Preserving Renal Function in Patients with Small Renal Masses: Results from the DISSRM Registry.
Matthew R Danzig, Rashed A Ghandour, Peter Chang, Andrew A Wagner, Phillip M Pierorazio

J Urol· October 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Renal cell carcinoma: risks and benefits of nephron-sparing surgery for T1 tumors.
Rashed A Ghandour, Matthew R Danzig, James M McKiernan

Adv Chronic Kidney Dis· July 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mixed low- and high-grade non-muscle-invasive bladder cancer: a histological subtype with favorable outcome.
Tina Schubert, Matthew R Danzig, Srinath Kotamarti, Rashed A Ghandour, Danny Lascano

World J Urol· June 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of the 2012 United States Preventive Services Task Force statement on prostate-specific antigen screening: analysis of urologic and primary care practices.
Tomy Y Perez, Matthew R Danzig, Rashed A Ghandour, Ketan K Badani, Mitchell C Benson

Urology· January 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reply: To PMID 25440819.
Rashed A Ghandour, James M McKiernan

Urology· January 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase II trial of intravesical nanoparticle albumin bound paclitaxel for the treatment of nonmuscle invasive urothelial carcinoma of the bladder after bacillus Calmette-Guérin treatment failure.
James M McKiernan, Dara D Holder, Rashed A Ghandour, LaMont J Barlow, Jennifer J Ahn

J Urol· December 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cost-effectiveness of neoadjuvant chemotherapy before radical cystectomy for muscle-invasive bladder cancer.
Scott M Stevenson, Matthew R Danzig, Rashed A Ghandour, Christopher M Deibert, G Joel Decastro

Urol Oncol· November 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
New agents for bacillus Calmette-Guérin-refractory nonmuscle invasive bladder cancer.
Jennifer J Ahn, Rashed A Ghandour, James M McKiernan

Curr Opin Urol· September 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The association between socioeconomic status, renal cancer presentation, and survival in the United States: a survival, epidemiology, and end results analysis.
Matthew R Danzig, Aaron C Weinberg, Rashed A Ghandour, Srinath Kotamarti, James M McKiernan

Urology· September 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis